Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 96

Results For "COVID"

1142 News Found

DCGI grants EUA to Truenat for conducting Nipah virus tests
Digitisation | September 09, 2021

DCGI grants EUA to Truenat for conducting Nipah virus tests

Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis


Equipment shortage and overpriced APIs pinch the pharma industry
News | September 09, 2021

Equipment shortage and overpriced APIs pinch the pharma industry

A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges


Metropolis Healthcare opens a new testing centre in Latur, Maharashtra
Healthcare | September 08, 2021

Metropolis Healthcare opens a new testing centre in Latur, Maharashtra

The lab will offer over 4,000 clinical tests and profiles and can conduct over 20,000 sample tests per month.


ABB’s ACS360 Drives enhance safety and energy efficiency at Bharat Biotech’s Covaxin plant
Biotech | September 07, 2021

ABB’s ACS360 Drives enhance safety and energy efficiency at Bharat Biotech’s Covaxin plant

ABB Drives play a key role in the cleanroom infrastructure of Bharat Biotech, India’s first indigenous Covid-19 vaccine manufacturer. The drives are easy to commission, use and ensure higher energy efficiency


Indian Pharmaceutical Market grew by 17.7 per cent in August
News | September 07, 2021

Indian Pharmaceutical Market grew by 17.7 per cent in August

Ind-Ra expects IPM revenue to grow over 12% YoY in FY22


Panacea Biotech supplies 1st shipment of the second component of Sputnik V vaccine
News | September 07, 2021

Panacea Biotech supplies 1st shipment of the second component of Sputnik V vaccine

The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories


Healthium Medtech files DRHP for IPO
Startup | September 07, 2021

Healthium Medtech files DRHP for IPO

As of FY21, it is the largest independent medical device company and the second-largest company overall, in the surgical consumables market in India with a 7.91 per cent share based on the value


Max Ventilator forms partnership with US-based Amptron Medical
Drug Approval | September 07, 2021

Max Ventilator forms partnership with US-based Amptron Medical

Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.


CRAMS to drive growth for Indian pharma industry: report
News | September 06, 2021

CRAMS to drive growth for Indian pharma industry: report

The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion


DGCI approves Hetero’s Tocilizumab
Drug Approval | September 06, 2021

DGCI approves Hetero’s Tocilizumab

Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month